The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ECHO-310: A phase 3, randomized trial of epacadostat + nivolumab + chemo vs EXTREME as first-line treatment of recurrent/metastatic SCCHN.
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Human Longevity, Inc; Merck; Pfizer
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Innate Pharma
Research Funding - Genentech
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Amanda Psyrri
Honoraria - Merck Serono
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pfizer
Other Relationship - Bristol-Myers Squibb; Janssen Oncology
 
Julie E. Bauman
Consulting or Advisory Role - AstraZeneca/MedImmune; Kolltan Pharmaceuticals; Merck; Merck Serono
Research Funding - AVEO; Bristol-Myers Squibb; Genentech; Lilly; Merck; VentiRx
 
Richard Schaub
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Li Zhou
Employment - Incyte; Merck Sharp & Dohme (I); Teclison (I)
Stock and Other Ownership Interests - Incyte
 
Li Li
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Vijayvel Jayaprakash
Employment - AstraZeneca; AstraZeneca (I); Bristol-Myers Squibb; Bristol-Myers Squibb (I); Sanofi; Sanofi (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Joel Guigay
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma; Merck Serono
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MERCK SERONO (Inst)